Prophase Labs Stock In The News

PRPH Stock  USD 5.06  0.10  1.94%   
The tone or emotional content of news articles related to ProPhase Labs can affect its prices. Positive news sentiment can lead to an increase in demand for ProPhase Labs' stock, while negative news sentiment can lead to a decrease in demand. Our overall analysis of ProPhase Labs' news coverage and content from conventional and social sources shows investors' bearish mood towards ProPhase Labs. The specific impact of ProPhase Labs news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of ProPhase Labs' overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using ProPhase Labs headlines in addition to utilizing other, more conventional financial analysis modules. Check out ProPhase Labs Backtesting and ProPhase Labs Hype Analysis.
For more detail on how to invest in ProPhase Stock please use our How to Invest in ProPhase Labs guide.

ProPhase Labs Today Top News and Investor Outlook

Macroaxis News: globenewswire.com
SHAREHOLDER ALERT: Kaskela Law LLC Annou...
https://www.globenewswire.com/news-release/2023/11/11/2778590/0/en/SHAREHOLDER-ALERT-Kaskela-Law-LLC-Announces-Investigation-of-ProPhase-Labs-Inc-NASDAQ-PRPH-and-Encourages-Investors-to-Contact-the-Firm.html
 Bullish
Macroaxis News: globenewswire.com
ProPhase Labs Announces Financial Results for the Three Months Ended September 30, 2023
https://www.globenewswire.com/news-release/2023/11/09/2777297/0/en/ProPhase-Labs-Announces-Financial-Results-for-the-Three-Months-Ended-September-30-2023.html
 Bullish
Macroaxis News: globenewswire.com
INVESTOR ALERT: Abbott Cooper PLLC Annou...
https://www.globenewswire.com/news-release/2023/11/04/2773574/0/en/INVESTOR-ALERT-Abbott-Cooper-PLLC-Announces-Investigation-into-ProPhase-Labs-Inc-Urges-ProPhase-Stockholders-to-Contact-Abbott-Cooper-Regarding-Their-Legal-Rights.html
 Bullish
Macroaxis News: globenewswire.com
ProPhase Labs to Host Third Quarter 2023 Financial Results Conference Call on Thursday, November 9, 2023 at 11:00 a.m. Eastern Time
https://www.globenewswire.com/news-release/2023/11/02/2772206/0/en/ProPhase-Labs-to-Host-Third-Quarter-2023-Financial-Results-Conference-Call-on-Thursday-November-9-2023-at-11-00-a-m-Eastern-Time.html
 Bullish
Macroaxis News: globenewswire.com
ProPhase Labs Announces Substantial Grow...
https://www.globenewswire.com/news-release/2023/10/17/2761436/0/en/ProPhase-Labs-Announces-Substantial-Growth-Expectations-for-Pharmaloz-Manufacturing-Subsidiary-due-to-Skyrocketing-Demand-for-Pharmaloz-Output.html
 Bullish
Macroaxis News: globenewswire.com
DSS Inc. Issues Letter to Shareholders
https://www.globenewswire.com/news-release/2023/10/12/2759232/0/en/DSS-Inc-Issues-Letter-to-Shareholders.html
 Bullish
Macroaxis News: globenewswire.com
ProPhase Labs to Present at The ThinkEquity Conference
https://www.globenewswire.com/news-release/2023/10/12/2759170/0/en/ProPhase-Labs-to-Present-at-The-ThinkEquity-Conference.html
 Bullish
Macroaxis News: globenewswire.com
ProPhase Labs Announces Updated Conferen...
https://www.globenewswire.com/news-release/2023/08/10/2722887/0/en/ProPhase-Labs-Announces-Updated-Conference-Call-Dial-in-Information-for-Thursday-August-10-2023-at-11-00-a-m-Eastern-Time-for-Second-Quarter-2023-Financial-Results-Call.html
 Bullish
Macroaxis News: globenewswire.com
ProPhase Labs Announces Financial Results for the Three Months Ended June 30, 2023
https://www.globenewswire.com/news-release/2023/08/10/2722616/0/en/ProPhase-Labs-Announces-Financial-Results-for-the-Three-Months-Ended-June-30-2023.html
 Bullish
Macroaxis News: globenewswire.com
ProPhase Labs Teams up with Certis Oncology to Accelerate Development of Novel Linebacker Compound
https://www.globenewswire.com/news-release/2023/08/03/2717966/0/en/ProPhase-Labs-Teams-up-with-Certis-Oncology-to-Accelerate-Development-of-Novel-Linebacker-Compound.html
 Bullish

ProPhase Labs Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide ProPhase and other traded companies coverage. We help investors stay connected with ProPhase headlines for the 25th of April to make an informed investment decision based on correlating the impacts of news items on ProPhase Stock performance. Please note that trading solely based on the ProPhase Labs hype is not for everyone as timely availability and quick action are needed to avoid losses.
ProPhase Labs' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help ProPhase Labs investors visualize upcoming and past events in order to time the market based on ProPhase Labs noise-free hype analysis.
ProPhase Labs stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the ProPhase earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about ProPhase Labs that are available to investors today. That information is available publicly through ProPhase media outlets and privately through word of mouth or via ProPhase internal channels. However, regardless of the origin, that massive amount of ProPhase data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of ProPhase Labs news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of ProPhase Labs relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to ProPhase Labs' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive ProPhase Labs alpha.

ProPhase Largest EPS Surprises

Earnings surprises can significantly impact ProPhase Labs' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2004-10-28
2004-09-300.020.030.0150 
1997-08-13
1997-06-300.080.07-0.0112 
2010-11-10
2010-09-300.090.06-0.0333 
2000-10-26
2000-09-30-0.020.010.03150 
1998-10-30
1998-09-300.230.2-0.0313 
1998-07-31
1998-06-30-0.041.0E-40.0401100 
View All Earnings Estimates

ProPhase Labs Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to ProPhase Labs Stock. The global stock market is bearish. About 60% of major world exchanges and indexes are down. See today's market update for more information.
Macroaxis News
23rd of April 2024
Acquisition by Louis Gleckel of 40000 shares of ProPhase Labs at 7.31 subject to Rule 16b-...
at MacroaxisInsider 
Macroaxis News: globenewswire.com
16th of April 2024
ProPhase Labs Unveils Project ZenQ-AI
at globenewswire.com 
Macroaxis News: globenewswire.com
2nd of April 2024
ProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635
at globenewswire.com 
news
19th of March 2024
Acquisition by Jason Barr of 70000 shares of ProPhase Labs at 6.0 subject to Rule 16b-3
at Jason Barr 
Yahoo News
18th of March 2024
ProPhase Labs, Inc. Q4 2023 Earnings Call Transcript
at finance.yahoo.com 
seekingalpha News
15th of March 2024
ProPhase Labs GAAP EPS of -0.98 misses by 0.24, revenue of 45.2M misses by 6.38M
at seekingalpha.com 
Google News at Macroaxis
12th of March 2024
O Shaughnessy Asset Management LLC Lowers Holdings in ProPhase Labs, Inc. - Defense World
at news.google.com 
Simply Wall St News at Macroaxis
4th of March 2024
Does This Valuation Of ProPhase Labs, Inc. Imply Investors Are Overpaying
at simplywall.st 
Yahoo News
21st of February 2024
Diamond Equity Research Releases Update Note on ProPhase Labs Inc.
at finance.yahoo.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards ProPhase Labs in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, ProPhase Labs' short interest history, or implied volatility extrapolated from ProPhase Labs options trading.
When determining whether ProPhase Labs offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ProPhase Labs' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Prophase Labs Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Prophase Labs Stock:
Check out ProPhase Labs Backtesting and ProPhase Labs Hype Analysis.
For more detail on how to invest in ProPhase Stock please use our How to Invest in ProPhase Labs guide.
You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Complementary Tools for ProPhase Stock analysis

When running ProPhase Labs' price analysis, check to measure ProPhase Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ProPhase Labs is operating at the current time. Most of ProPhase Labs' value examination focuses on studying past and present price action to predict the probability of ProPhase Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ProPhase Labs' price. Additionally, you may evaluate how the addition of ProPhase Labs to your portfolios can decrease your overall portfolio volatility.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Is ProPhase Labs' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ProPhase Labs. If investors know ProPhase will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ProPhase Labs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.95)
Earnings Share
(0.98)
Revenue Per Share
2.579
Quarterly Revenue Growth
(0.84)
Return On Assets
(0.15)
The market value of ProPhase Labs is measured differently than its book value, which is the value of ProPhase that is recorded on the company's balance sheet. Investors also form their own opinion of ProPhase Labs' value that differs from its market value or its book value, called intrinsic value, which is ProPhase Labs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProPhase Labs' market value can be influenced by many factors that don't directly affect ProPhase Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ProPhase Labs' value and its price as these two are different measures arrived at by different means. Investors typically determine if ProPhase Labs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProPhase Labs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.